EARNEST Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,183
Closed -$122K 790
2023
Q3
$122K Hold
1,183
﹤0.01% 311
2023
Q2
$137K Hold
1,183
﹤0.01% 294
2023
Q1
$126K Hold
1,183
﹤0.01% 289
2022
Q4
$131K Hold
1,183
﹤0.01% 292
2022
Q3
$102K Hold
1,183
﹤0.01% 285
2022
Q2
$108K Hold
1,183
﹤0.01% 284
2022
Q1
$97K Hold
1,183
﹤0.01% 294
2021
Q4
$91K Hold
1,183
﹤0.01% 304
2021
Q3
$89K Hold
1,183
﹤0.01% 296
2021
Q2
$92K Sell
1,183
-57
-5% -$4.24K ﹤0.01% 289
2021
Q1
$91K Hold
1,240
﹤0.01% 281
2020
Q4
$97K Hold
1,240
﹤0.01% 272
2020
Q3
$98K Sell
1,240
-70
-5% -$5.48K ﹤0.01% 261
2020
Q2
$97K Hold
1,310
﹤0.01% 261
2020
Q1
$96K Hold
1,310
﹤0.01% 260
2019
Q4
$114K Hold
1,310
﹤0.01% 264
2019
Q3
$105K Hold
1,310
﹤0.01% 271
2019
Q2
$105K Hold
1,310
﹤0.01% 272
2019
Q1
$104K Hold
1,310
﹤0.01% 270
2018
Q4
$96K Hold
1,310
﹤0.01% 266
2018
Q3
$89K Hold
1,310
﹤0.01% 271
2018
Q2
$76K Sell
1,310
-70
-5% -$3.95K ﹤0.01% 276
2018
Q1
$72K Hold
1,380
﹤0.01% 281
2017
Q4
$74K Buy
+1,380
New +$76.5K ﹤0.01% 271
2017
Q1
Sell
-1,380
Closed -$78K 652
2016
Q4
$78K Buy
+1,380
New +$80.8K ﹤0.01% 253

Other funds holding MRK

EARNEST Partners's MRK Position: Q4 2023 in Review

EARNEST Partners sold out of Merck (MRK) in Q4 2023, closing a stake of 1,183 shares — an estimated $122K sold.

EARNEST Partners first reported a position in MRK in Q4 2016 and held it in 25 quarters. The position peaked at $137K in Q2 2023. 3,439 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • EARNEST Partners reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • EARNEST Partners sold 1,183 Merck shares in Q4 2023, an estimated $122K.
  • EARNEST Partners first reported a position in Merck in Q4 2016 and held it in 25 quarters.
  • EARNEST Partners's Merck position peaked at $137K in Q2 2023.
  • 3,439 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.